NCT00279903 - Is Botox Effective in Relieving Pain From Knee Osteoarthritis? | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Osteoarthritis, Knee

Interventions

DRUG

Botulinum toxin type A (Btx-A)

Participants randomized to Btx-A will be given either a low dose of 100 units or a high dose of 200 units. The Btx-A dose (100U or 200U) will be resonstituted with 4 cc of sterile non-preserved 0.9% sodium chloride solution.

DRUG

Cortisone

1 cc of 40 mg/cc methylprednisolone will be drawn up in 22 gauge needles with 3 cc of sterile non-preserved 0.9% sodium chloride solution.

Trial Locations (1)

55905

Mayo Clinic, Rochester